NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to unify and standardize pharmaceutical logistics quality standards on a global basis.

The Nippon Express Group has positioned the pharmaceutical industry as a key industry in its "Nippon Express Group Business Plan 2023 -- Dynamic Growth" and has acquired Good Distribution Practice (GDP), CEIV Pharma and other certifications for pharmaceutical logistics at 34 business locations in 24 countries/regions to meet increasingly stringent and diverse pharmaceutical logistics needs as the Group develops a safe and secure worldwide pharmaceutical logistics network centered on these certifications.

To provide high-quality pharmaceutical logistics services to customers in the pharmaceutical industry, the Nippon Express Group has been working to establish a globally unified and standardized quality management system and has recently compiled the NX-Pharma Global Quality Manual. In addition to further improving the quality of its existing transport, storage, and other services, the Group is striving to build a pharmaceutical logistics platform that creates new value.

Furthermore, the Group has newly established Pharmaceutical Logistics Global Quality Assurance Division within the Global Business Headquarters and appointed Head of NX-Pharma Global Quality to bolster the quality management system on a global level.